MD Varun Mangla steps down; new MD/CFO and Independent Director appointed

CEO resignedKey managerial personnel resignedExternal CEO appointedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.3%Reaction day

₹15.46

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.1% vs market

Trading & Distributors peers, median of 130sector+0.0%+0.3% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.3 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.3+0.2+0.1+0.0+0.3

Next day

-1.0+0.2-1.3+0.0-1.0

+0.3+0.4-0.1-0.5+0.7

-4.3+0.7-5.0-1.2-3.1

-8.2+0.1-8.3-1.1-7.0

-0.3+0.7-0.9-1.3+1.0

-6.2+1.2-7.4-1.3-4.9

15d

+0.1+0.7-0.6-2.5+2.6

+4.4-1.2+5.6-4.4+8.8

+30.7-1.1+31.9-6.7+37.4

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 130Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Managing Director Varun Mangla resigned due to pre-occupation but continues as Director. Ms. Sangeeta Harpalani (Ph.D, FCS, ACMA, 20+ years experience in governance and finance) appointed as Additional Director, to be designated as Managing Director and CFO. Mr. Amit Kapoor (CA, PGDBA, 19+ years experience in outsourcing and banking) appointed as Additional Independent Director. All changes effective August 11, 2026.

Likely market impact

Top-level leadership reshuffle with MD exit and external replacement. Outgoing MD retains board seat, ensuring some continuity. New MD/CFO brings deep finance and compliance expertise.